Trial · NCT02876835
Adverse events2,310
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,310
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hypertension | Vascular disorders | Run-in Period: Placebo | 0 | 3,872 | 0 |
| other | Hypertension | Vascular disorders | Daprodustat | 247 | 1,937 | 317 |
| other | Hypertension | Vascular disorders | Darbepoetin Alfa | 264 | 1,933 | 339 |
| other | Oedema peripheral | General disorders | Run-in Period: Placebo | 0 | 3,872 | 0 |
| other | Oedema peripheral | General disorders | Daprodustat | 198 | 1,937 | 239 |
| other | Oedema peripheral | General disorders | Darbepoetin Alfa | 162 | 1,933 | 199 |
| other | Urinary tract infection | Infections and infestations | Run-in Period: Placebo | 0 | 3,872 | 0 |
| other | Urinary tract infection | Infections and infestations | Daprodustat | 164 | 1,937 | 245 |
| other | Urinary tract infection | Infections and infestations | Darbepoetin Alfa | 153 | 1,933 | 199 |
| other | Diarrhoea | Gastrointestinal disorders | Run-in Period: Placebo | 0 | 3,872 | 0 |
| other | Diarrhoea | Gastrointestinal disorders | Daprodustat | 149 | 1,937 | 181 |
| other | Diarrhoea | Gastrointestinal disorders | Darbepoetin Alfa | 139 | 1,933 | 172 |
| other | Nasopharyngitis | Infections and infestations | Run-in Period: Placebo | 0 | 3,872 | 0 |
| other | Nasopharyngitis | Infections and infestations | Daprodustat | 118 | 1,937 | 163 |
| other | Nasopharyngitis | Infections and infestations | Darbepoetin Alfa | 133 | 1,933 | 180 |
| other | Hyperkalaemia | Metabolism and nutrition disorders | Run-in Period: Placebo | 0 | 3,872 | 0 |
| other | Hyperkalaemia | Metabolism and nutrition disorders | Daprodustat | 128 | 1,937 | 148 |
| other | Hyperkalaemia | Metabolism and nutrition disorders | Darbepoetin Alfa | 122 | 1,933 | 141 |
| other | Constipation | Gastrointestinal disorders | Run-in Period: Placebo | 0 | 3,872 | 0 |
| other | Constipation | Gastrointestinal disorders | Daprodustat | 127 | 1,937 | 150 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02876835/events